Data as of Apr 17
| +0.21 / +0.37%|
The 18 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 59.50, with a high estimate of 70.00 and a low estimate of 44.00. The median estimate represents a +5.37% increase from the last price of 56.47.
The current consensus among 22 polled investment analysts is to Hold stock in Merck & Co Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.